CD31 Chemokines Maladie auto-immune Cardiomyopathy Conduction disease Thymus Myasthénie grave Th17 cells Interferon Inflammatory cytokines CXCL13-CXCR5 Interleukin 23 Etiology Autoimmunity B cells Adaptive immunity Acides nucléiques endogènes DICER Experimental mouse models BAFF Human myoblasts Immune regulation Interféron de type I Cellules th17 FMR1 MiR-125 LMNA Mass cytometry CyTOF Antimir-150 MiR-7 Anticorps monoclonal Max Interferon IFN CTCF Glucocorticoids Autoimmune diseases Heart failure Endogenous nucleic acids Genetics Gender Genetic associations Interleukine-23 Myasthenia gravis COX2 Ectopic germinal centers Thymic epithelial cells Early-onset myasthenia gravis Interferon de type I MYB COVID-19 Neuromuscular junction Immunity M3243AG Chemokine Clinical cell transplantation Germinal center Gd T cells Transcriptome Germinal centers Interferon type I Acetylcholine receptor Cytokines Acetylcholine receptors CCL21 Autoimmune disease Immunology and Microbiology Section Myasthenia Gravis MG Experimental autoimmune myasthenia gravis Immune response Animal models Quality of life Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype MG patients Myoblasts AChR antibodies Interferon type-I Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Thymoma Interferonopathy Chronic inflammation PBMC Auto-immunité Ferrites Macrophages Fragile X syndromes Centres germinatifs ectopiques Lamin A/C nuclei Innate immunity Experimental models Complete Freund's adjuvant Disease susceptibility Chronicity Il-23 Inflammation Acetylcholine receptor antibodies Interferon-β Immunotherapy Long-term follow-up Experimental autoimmune myasthenia gravis EAMG Exercise